Will taking dasatinib cause hair loss?

Dasatinib has been reported to cause hair loss in 1% to less than 10% of patients, but it is not listed as a common side effect. The hair loss data reported by the manufacturer are based on data collected from 2809 participants in pooled studies evaluating the use of dasatinib in adults with chronic myelogenous leukemia (CML) and Philadelphia chromosome-positive acute lymphoblastic leukemia (Ph+ALL).

Dasatinib may also rarely cause changes in hair color (depigmentation); one case report of a 56-year-old woman described depigmentation that began 2 months after starting dasatinib treatment for chronic myelogenous leukemia. Depigmentation worsens after 12 months and is reversible 2 to 3 months after stopping treatment. Alopecia has not been specifically noted, and skin depigmentation of the face and trunk has also been reported. Other common and serious side effects associated with antibiotic treatment can be found in Important Tips for Dasatinib. If the patient experiences hair loss during or after treatment with dasatinib, it is recommended to communicate with the doctor in time. The doctor may understand the specific situation through relevant examinations.

The original drug of dasatinib has been launched in China and is included in the medical insurance. Currently, reimbursement is only available to eligible patients. Common specifications The price of each box of 50mg*60 tablets may be around RMB 10,000. The original drug overseas is even more expensive. Dasatinib generics are also sold overseas. The ingredients of the drug are basically the same as those sold domestically and abroad, but the price is cheap. For example, the price of a box of 50mg*60 tablets produced by an Indian pharmaceutical factory may be several hundred yuan (the price may fluctuate due to exchange rates).